Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol-Reference-Cited by-同舟云学术

Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol

Published:2014-03 Issue: Volume:68 Page:79-88
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Ruiz-Meana Marisol,Núñez Estefanía,Miro-Casas Elisabet,Martínez-Acedo Pablo,Barba Ignasi,Rodriguez-Sinovas Antonio,Inserte Javier,Fernandez-Sanz Celia,Hernando Victor,Vázquez Jesús,Garcia-Dorado David

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference48 articles.

1. Preconditioning delays Ca2+-induced mitochondrial permeability transition;Argaud;Cardiovasc Res,2004

2. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria;Baines;Circ Res,2003

3. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning;Boengler;Cardiovasc Res,2005

4. Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption;Boengler;J Cell Mol Med,2012

5. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria;Boengler;Basic Res Cardiol,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction;Journal of Translational Medicine;2024-04-26

2. Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury;Antioxidants;2024-01-16

3. Mitochondria isolated from lipid droplets of white adipose tissue reveal functional differences based on lipid droplet size;Life Science Alliance;2023-12-06

4. Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases;International Journal of Molecular Sciences;2023-03-30

5. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning;Pharmacological Reviews;2022-12-08